Hadassah Medical Organization Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2014
NCT02148978
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dimitrios Karussis | Donna R Zwas | Doron Aframian | Jeff Weinberger | Liran Levy

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Facial Pain (Phase 4)

Fistula (Phase 2)

Multiple Sclerosis (Phase 2)

Myalgia (Phase 4)

Sclerosis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 7